ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,113, issued on Oct. 20, was assigned to CASE WESTERN RESERVE UNIVERSITY (Cleveland).
"Cellular retinoid binding protein antagonists and uses thereof" was invented by Marcin Bernard Golczak (Cleveland) and Josie Ann Silvaroli (Cleveland).
According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating an ocular, inflammatory, immune, and/or metabolic disorder in a subject in need thereof includes administering to the subject a therapeutically effective amount of a compound having a structure of formula (I)."
The patent was filed on June 7, 2019, under Application No. 15/734,781.
*For further information, including images, charts and tables, pleas...